Display options
Cite
Almansour H, Afat S, Fritz V, et al. Prospective Image Quality and Lesion Assessment in the Setting of MR-Guided Radiation Therapy of Prostate Cancer on an MR-Linac at 1.5 T: A Comparison to a Standard 3 T MRI. Cancers (Basel). 2021;13(7)doi: 10.3390/cancers13071533.
Almansour, H., Afat, S., Fritz, V., Schick, F., Nachbar, M., Thorwarth, D., Zips, D., Müller, A. C., Nikolaou, K., Othman, A. E., & Wegener, D. (2021). Prospective Image Quality and Lesion Assessment in the Setting of MR-Guided Radiation Therapy of Prostate Cancer on an MR-Linac at 1.5 T: A Comparison to a Standard 3 T MRI. Cancers, 13(7), . https://doi.org/10.3390/cancers13071533
Almansour, Haidara, et al. "Prospective Image Quality and Lesion Assessment in the Setting of MR-Guided Radiation Therapy of Prostate Cancer on an MR-Linac at 1.5 T: A Comparison to a Standard 3 T MRI." Cancers vol. 13,7 (2021). doi: https://doi.org/10.3390/cancers13071533
Almansour H, Afat S, Fritz V, Schick F, Nachbar M, Thorwarth D, Zips D, Müller AC, Nikolaou K, Othman AE, Wegener D. Prospective Image Quality and Lesion Assessment in the Setting of MR-Guided Radiation Therapy of Prostate Cancer on an MR-Linac at 1.5 T: A Comparison to a Standard 3 T MRI. Cancers (Basel). 2021 Mar 26;13(7). doi: 10.3390/cancers13071533. PMID: 33810410; PMCID: PMC8036991.
Copy Download .nbib Format: NLM
Share it on

Cancers (Basel). 2021 Mar 26;13(7). doi: 10.3390/cancers13071533.

Prospective Image Quality and Lesion Assessment in the Setting of MR-Guided Radiation Therapy of Prostate Cancer on an MR-Linac at 1.5 T: A Comparison to a Standard 3 T MRI.

Cancers

Haidara Almansour, Saif Afat, Victor Fritz, Fritz Schick, Marcel Nachbar, Daniela Thorwarth, Daniel Zips, Arndt-Christian Müller, Konstantin Nikolaou, Ahmed E Othman, Daniel Wegener

Affiliations

  1. Department of Diagnostic and Interventional Radiology, Eberhard-Karls University, 72076 Tuebingen, Germany.
  2. Section for Experimental Radiology, Department of Radiology, Eberhard-Karls University, 72076 Tuebingen, Germany.
  3. Section for Biomedical Physics, Department of Radiation Oncology, Eberhard-Karls University, 72076 Tuebingen, Germany.
  4. German Cancer Consortium (DKTK), Partner Site Tuebingen and German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.
  5. Department of Radiation Oncology, Eberhard-Karls University, 72076 Tuebingen, Germany.
  6. Department of Neuroradiology, University Medical Center Mainz, 55131 Mainz, Germany.

PMID: 33810410 PMCID: PMC8036991 DOI: 10.3390/cancers13071533

Abstract

The objective of this study is to conduct a qualitative and a quantitative image quality and lesion evaluation in patients undergoing MR-guided radiation therapy (MRgRT) for prostate cancer on a hybrid magnetic resonance imaging and linear accelerator system (MR-Linac or MRL) at 1.5 Tesla. This prospective study was approved by the institutional review board. A total of 13 consecutive patients with biopsy-confirmed prostate cancer and an indication for MRgRT were included. Prior to radiation therapy, each patient underwent an MR-examination on an MRL and on a standard MRI scanner at 3 Tesla (MRI

Keywords: MR-Linac; PIRADS; adaptive radiotherapy; image guidance; image quality; lesion detection; mpMRI; prostate carcinoma

References

  1. Eur J Radiol. 2017 May;90:192-197 - PubMed
  2. Magn Reson Imaging. 2012 Nov;30(9):1216-23 - PubMed
  3. Int J Radiat Oncol Biol Phys. 2018 Aug 1;101(5):1057-1060 - PubMed
  4. Strahlenther Onkol. 2001 Feb;177(2):59-73 - PubMed
  5. Adv Radiat Oncol. 2017 Mar 28;2(3):429-436 - PubMed
  6. Biometrics. 1977 Mar;33(1):159-74 - PubMed
  7. Phys Med Biol. 2017 Nov 14;62(23):L41-L50 - PubMed
  8. Radiother Oncol. 2020 Oct;151:88-94 - PubMed
  9. Magn Reson Imaging. 2015 Sep;33(7):939-49 - PubMed
  10. Radiology. 2014 Apr;271(1):143-52 - PubMed
  11. Invest Radiol. 2015 Sep;50(9):594-600 - PubMed
  12. Tutor Quant Methods Psychol. 2012;8(1):23-34 - PubMed
  13. Radiother Oncol. 2019 Apr;133:156-162 - PubMed
  14. Med Phys. 2019 Jul;46(7):3044-3054 - PubMed
  15. Invest Radiol. 2015 Nov;50(11):785-91 - PubMed
  16. AJR Am J Roentgenol. 2005 Nov;185(5):1214-20 - PubMed
  17. Front Oncol. 2020 Sep 02;10:1741 - PubMed
  18. Br J Radiol. 2019 Feb;92(1094):20180505 - PubMed
  19. Mol Oncol. 2020 Jul;14(7):1470-1491 - PubMed
  20. Z Med Phys. 2016 Jun;26(2):168-76 - PubMed
  21. Med Phys. 2018 Mar;45(3):1204-1209 - PubMed
  22. Eur Urol. 2016 Jan;69(1):16-40 - PubMed
  23. Invest Radiol. 2018 Apr;53(4):200-206 - PubMed

Publication Types

Grant support